Neptune Technologies & Bioressources Inc.
Head Quarters
bureau 100 545, Promenade du Centropolis USWebsite
http://www.neptunebiotech.comIndustry
BiotechnologyEmployees
139Exchange
NASDAQNeptune Technologies & Bioresources, Inc. engages in the development and commercialization of marine derived omega-3 polyunsaturated fatty acids. It operates through three segments: Neptune, Acasti and NeuroBio. The Neptune segment involves the production and commercialization of nutraceutical products. The Acasti segment involves the development and commercialization of medical food and pharmaceutical products for cardiovascular diseases. The NeuroBio segment involves the development of medical food and pharmaceutical products for neurological diseases. The company was founded by Henri Harland on October 9, 1998 and is headquartered in Laval, Canada.
Key statistics
| Margins | Stock |
|---|---|
| Revenue per Employee | $0.00 |
| Current Ratio | 2 |
| Gross Margin (%) | 0.24% |
| Net Margin (%) | 0.24% |
| Returns | Stock |
| Sales | $33.00M |
| Sales Growth (% qtr vs. yr ago) | 0.00% |
| Net Income | $0.00 |
| NI Growth (% qtr vs. yr ago) | 0.00% |
| Price/Sales | 1.73 |
| EPS | $0.00 |